Grifols (MEX:GRF N) Days Sales Outstanding : 38.79 (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Grifols Days Sales Outstanding?

Grifols's average Accounts Receivable for the three months ended in Dec. 2024 was MXN18,342.17 Mil. Grifols's Revenue for the three months ended in Dec. 2024 was MXN43,148.65 Mil. Hence, Grifols's Days Sales Outstanding for the three months ended in Dec. 2024 was 38.79.

The historical rank and industry rank for Grifols's Days Sales Outstanding or its related term are showing as below:

MEX:GRF N' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.59 Med: 30.76 Max: 40.04
Current: 50.26

During the past 13 years, Grifols's highest Days Sales Outstanding was 40.04. The lowest was 22.59. And the median was 30.76.

MEX:GRF N's Days Sales Outstanding is ranked better than
73.52% of 948 companies
in the Drug Manufacturers industry
Industry Median: 72.635 vs MEX:GRF N: 50.26

Grifols's Days Sales Outstanding declined from Sep. 2023 (48.20) to Dec. 2024 (38.79).

Grifols Days Sales Outstanding Historical Data

The historical data trend for Grifols's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grifols Days Sales Outstanding Chart

Grifols Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

24.04

30.79

32.93

36.67

31.69

Grifols Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23	Jun24	Sep24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial															48.20	39.08	34.10	42.07	38.79

Competitive Comparison of Grifols's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, Grifols's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grifols's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grifols's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Grifols's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Grifols Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Grifols's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (11941.448	+	15405.964)	/	2 )	/	157507.095	*	365
=	13673.706					/	157507.095	*	365
=	31.69

Grifols's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (21278.374	+	15405.964)	/	2 )	/	43148.653	*	365 / 4
=	18342.169					/	43148.653	*	365 / 4
=	38.79

Grifols (MEX:GRF N) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Grifols Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Grifols's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Grifols Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Grifols SA (MEX:GRF N) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

GIKLY:USA GIFLF:USA GRFS:USA 1GRF:Italy GRFe:UK GRFPe:UK 0RDV:UK 0RDU:UK GRF.P:Spain GRF:Spain G0F0:Germany G0F0:Germany OZTA:Germany OZTA:Germany G0FB:Germany GRF:Austria

Address

Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174

Website

https://www.grifols.com

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Grifols Headlines

No Headlines